Glaxosmithkline Share News (GSK)

Reuters Health News Summary

Following is a summary of current health news briefs. Children risk serious injuries on golf carts Golf cart crashes involving children can result in serious injuries, a new study as

Reuters Health News Summary

Following is a summary of current health news briefs. Children risk serious injuries on golf carts Golf cart crashes involving children can result in serious injuries, a new study as

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division

* GSK reallocating budget to key new drugs, top 10 markets * Pharma head says commercial revamp matches R&D changes * Cancer a big pipeline focus, promise lies from Ben March 21

BUZZ-GSK partner Adaptimmune jumps on good cell therapy data

** Adaptimmune up 30 percent on news that second solid tumour type responds to its cell therapy, boosting hopes for biotech company's NY-ESO SPEAR T-cells partnered Adaptimmune reports three

UPDATE 1-Drugmaker Hikma's FY profit, revenue meet expectations; shares rise

March 14 (Reuters) - Hikma Pharmaceuticals Plc reported full-year profit and revenue largely in line with expectations, aided by strong performance in the second half of the year. The has a

RPT-Reckitt CEO stands by Mead Johnson deal, despite Pfizer option

* Mead Johnson gave Reckitt more new things * Some see Pfizer consumer unit as stretch for Reckitt * Mead Johnson performance has improved since purchase By Martinne March 10

Reckitt CEO stands by Mead Johnson deal, despite Pfizer option

* Mead Johnson gave Reckitt more new things * Some see Pfizer consumer unit as stretch for Reckitt * Mead Johnson performance has improved since purchase By Martinne March 10

TOP NEWS: GlaxoSmithKline Gets EU Approval For Wider Relvar Drug Use

LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday its asthma and chronic obstructive pulmonary disease drug Relvar Ellipta has received a "positive" EU with

London close: FTSE mixed as Unilever flies after rebuffed Kraft Heinz bid

(ShareCast News) - London stocks closed mixed after a Friday session that saw blue-chip consumer goods giant Unilever fly higher after it slapped away a $143bn offer from Kraft Heinz, which has indicated it will return to the table. The rebuffed offer -- $50 a share in a mix of cash and shares -- wa

LONDON MARKET CLOSE: Unilever Bid Helps FTSE 100 End Week Higher

European shares retreat after week of gains; Allianz rallies after update

* STOXX 600 down 0.5 pct, but remains close to 13-month high * Allianz surges after strong update, stock buyback plan * Drugmaker Stada gains after third takeover approach * Banking stocks, miners slip on profit taking * Vopak sees no profit growth, shares slump * Li

LONDON MARKET CLOSE: Sterling Rebound, Ex-Divs Send UK Stocks Lower

UPDATE 1-Milan mayor sees EU picking new home for drugs agency by June

(Adds task force and tax incentives) By Mark Bendeich MILAN, Feb 16 (Reuters) - The European Union is likely to select a new home for the bloc's London-based medicines regulator by June, according to the mayor of Milan, one of several cities vying to host the organisation after Brexit

Milan mayor sees EU picking new home for drugs agency by June

By Mark Bendeich MILAN, Feb 16 (Reuters) - The European Union is likely to select a new home for the bloc's London-based medicines regulator by June, according to the mayor of Milan, one of several cities vying to host the organisation after Brexit. The European Medicines Agency (EMA)

Vectura Hits GBP9 Million Royalty Cap Under Skyepharma Legacy Deal